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Factor I-catalyzed C4b cleavage is a regulatory reaction for the classical pathway of the complement system. 
Although the reaction was shown to be a two-step reaction, (i) production of a nicked form of C4b, C4b’, 
as an intermediate cleavage product and (ii) subsequent splitting of C4b’ into C4c and C4d, it is not known 
which of the two steps represents the inactivation of the C4b function in the assembly of C3 convertase, 
C4b,2a. We have purified C4b’ and assessed the ability of C4b’ to assemble C3 convertase with C2 by utiliz- 
ing size exclusion high performance liquid chromatography. Evidence was obtained demonstrating that 
C4b’ still retains the function of C4b to assemble C3 convertase. Thus, the substantial step for the inactiva- 
tion of the C4b function appears to be the second cleavage reaction, that is, the cleavage of C4b’ into C4c 
and C4d. 
Complement C3 convertase nicked C4h HPLC Molecular assembly 
1. INTRODUCTION 
The fourth component of human complement, 
C4, is a glycoprotein of 200000 Da composed of 
three disulfide-linked polypeptide chains, cr 
(94 kDa), ,& (75 kDa), and y (35 kDa) [ 11. The role 
of C4 in the complement system is to assemble C3 
convertase, which is a labile complex composed of 
C4b and C2a, C4b,2a [2]. The activation of C3 
convertase consists of the following three steps; in- 
itial cleavage of C4 with Cls into C4a (9 kDa) and 
C4b (190 kDa), binding of C4b with C2 in the 
presence of Mg2+, and subsequent cleavage of 
C4b-C2 complex by Cls into C4b,2a and C2b 
[2-51. The cleavage of C4 by Cls occurs on the a 
chain and generates on C4b molecule at least two 
different binding sites; one is a labile binding site 
to immune complexes [6,7] and another is a stable 
binding site for C2 [2-51. The function of C4b to 
assemble C3 convertase is controlled by two 
plasma proteins, C4b-binding protein (C4bp) [8] 
and factor I [9]. C4bp binds with C4b to induce I- 
catalyzed C4b-cleavage which occurs on the LY’ 
chain and yields two functionally inactive 
fragments, C4c (140 kDa) and C4d (45 kDa) [8]. 
We previously reported that a nicked form of C4b, 
C4b ’ , with the same molecular mass as C4b was 
generated as an intermediate cleavage product 
[ 111. Although the formation of nicked C4b was 
later confirmed by several groups [ 11,121, it still re- 
mained to be determined whether C4b ’ still retains 
the functional activity to generate C3 convertase. 
Evidence will be presented demonstrating that the 
nicked C4b is an active C4b derivative. Thus, in 
contrary to C3b cleavage, in which formation of a 
nicked C3b represents the inactivation of C3b 
[12,13], the cleavage of C4b’ into C4c and C4d 
represents a true inactivation step of the C4b 
function. 
2. MATERIALS AND METHODS 
Human complements, such as C2 [14], C4b [14], 
C3 [13], C4bp [15], I [lo] and Cis [16], were 
prepared as previously described. Nicked C4b was 
purified following the method described in [lo]; in 
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brief, C4b was incubated with I and C4bp at 37°C 
so as to achieve almost 50% conversion of C4b in- 
to C4c and C4d, as judged by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) and subsequently 
subjected preparatively to disc-PAGE. One gel was 
stained, and the unstained gels were sliced by refer- 
ring to the stained gel. The gel segments corre- 
sponding to C4b, which showed the same mobility 
on disc-PAGE as C4b, were collected and ex- 
tracted with 40 mM Tris-HCl buffer, pH 7.4, at 
37°C for 16 h. This method is based on evidence 
that when the C4b cleavage reaction goes up to 
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Fig.1. SDS-PAGE of C4b and nicked C4b, C4b’. C4b 
and C4b’ were subjected to SDS-PAGE for 60 min at 
8 mA per tube using 5.6% acrylamide gels before (A) or 
after (B) treatment with 2-mercaptoethanol. The bands 
of (~‘-1 and fl chains of C4b’ were overlapping each 
other to give a broad band in track B. The overloading 
of C4b’ (30,~g) in track B was to show the a’-2 band, 
which is cy’ 16 fragment from the carboxy-terminal end 
of the cy’ chain and is only faintly stained by the 
Coomassie blue-staining method. Since the overloading 
of C4b’ in track B made assessment of the absence of 
C4b in the C4b’ preparation difficult, prolonged SDS- 
PAGE was performed for 90 min at 8 mA per tube with 
proper amounts of reduced C4b’ (6pg) (C). Track C 
showed that C4b was absent in the C4b’ preparation. 
However, the cu’-2 band of C4b’ was not stained in 
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Fig.2. Demonstration of assembly of C3 convertase by 
HPLC. 2rg of C4b or C4b’ and different amounts of 
oxy C2 were incubated with C 1s in 50 pl of 20 mM Tris- 
HCl buffer, pH 7.4, containing 10 mM MgClz for 5 min 
at 37°C and subjected to HPLC using TSK G3OOOSW 
column equilibrated with 0.1 M phosphate buffer, pH 
6.8, at 20°C. Elution of proteins was determined by 
measuring the absorbance at 220 nm. A. C4b control 
(a). The molar ratios of C4b to oxy C2 were 1: 1 (b), 1: 2 
(c), 1 : 4 (d) and 1 : 6 (e). B. The molar ratio of C4b to oxy 
C2 were 1: 1 (f), 1: 2 (g) and 1: 4 (h). The amounts of Cls 
were adjusted to 1: 10 (w/w) of the amounts of oxy C2. 
The peak of C2b which was eluted broadly between 40 
track C, because of low amount of applied C4b’. and 45 min was omitted from the chart. 
almost 50% cleavage, the remaining C4b is already 
converted into the nicked form, C4b’ [lo]. Fig.1 
shows SDS-PAGE of the purified C4b’, which was 
composed of four bands; a’ -1 fragment (75 kDa), 
,B (75 kDa), y (33 kDa) and aI-2 fragment 
(16 kDa). The ability of C4b’ to assemble C3 con- 
vertase was determined by measuring the amounts 
of C3 convertase (270 kDa), which was separated 
by size exclusion HPLC using TSK G3000 SW col- 
umn (Toyo Soda Mfg, Japan) [14]. In addition, 
the enzymatic activity of C3 convertase to cleave 
C3 into C3a and C3b was determined by measuring 
the formation of C3b by disc-PAGE, in which C3b 
migrates more to the anodal side than C3. The per- 
cent cleavage of C3 was determined by den- 
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sitometrically scanning the Coomassie blue-stained which corresponds to C4b or C4b’ decreased with 
gels at 550 nm. For the recovery of stable C3 con- the increase of C3 convertase. When the percent 
vertase, iodine-treated C2, oxy C2 [2], was used. conversion of C4b’ into C3 convertase was com- 
Protein concentrations were estimated from the pared with that of intact C4b, the two curves were 
absorbance at 280 nm, assuming an absorption almost overlapping (fig.3). These results 
coefficient value of 0.1% solution = 1 .O. SDS- demonstrate that the nicked form of C4b still re- 
PAGE and disc-PAGE were performed as in [17] tains the ability to assemble C3 convertase as intact 
and [ 181, respectively. C4b. 
3. RESULTS 
Previously, we reported that HPLC using TSK 
G3000SW column was effective for the analysis of 
activation of C3 convertase; it clearly separates C3 
convertase from C4b, Cls, C2a and C2b [14]. 
Then, the ability of C4b’ to assemble C3 conver- 
tase was determined by measuring the amounts of 
C3 convertase separated by HPLC and compared 
with that of intact C4b. C4b or C4b’ was mixed 
with different amounts of oxy C2 in the presence 
of 10 mM MgC12 incubated with Cls for 5 min at 
37”C, and subjected to HPLC. Fig.2 shows the 
elution patterns of proteins. The peak eluted at 
27 min represents the elution of C3 convertase and 
was found to increase with the increase of amounts 
of oxy C2. Conversely, the peak eluted at 30 min, 
We next assessed whether the C3 convertase 
assembled from the nicked C4b was indeed func- 
tionally active complex, Then, two C3 convertase 
preparations assembled from intact C4b and 
nicked C4b were isolated by HPLC and incubated 
with C3. As shown in fig.4, the C3 cleaving ac- 
tivities of the two C3 convertase preparations were 
found to be similar. Thus, it was shown that the 
nicked C4b was not an inactive derivative of C4b 
but an active intermediate produced during the I- 
catalyzed C4b cleavage reaction. 
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Fig.3. Comparison of the C3 convertase-forming ability 
of C4b’ with that of intact C4b. The percent conversion 
of C4b (0) or C4b’ (0) into C3 convertase in the 
presence of different amounts of oxy C2 was estimated 
from the ratio of peak-area of C3 convertase to the sum 
of the peak-areas of C4b or C4b’ and C3 convertase of 
fig.2. 
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Fig.4. Comparison of C3-cleaving activity of the two C3 
convertases assembled from C4b or C4b’. C3 convertase 
was assembled from C4b or C4b’ and isolated by HPLC 
as in fig.3. The C3 convertase fractions were adjusted to 
a protein concentration of approx. 1 pg/ml. Then, 25 pg 
of C3 were incubated with different amounts of C3 
convertase assembled from C4b (0) or C4b’ (0) for 
30 min at 37°C and subjected to disc-PAGE without 
reduction. The percent conversion of C3 into C3b was 
estimated by densitometric scanning of the Coomassie- 
blue stained gels at 550 nm. 
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4. DISCUSSION ACKNOWLEDGEMENTS 
C4b and C3b are constituents of C3 convertase 
of the classical and alternative pathways of the 
complement system, respectively, and the 
cleavages of C4b and C3b by factor I are critical 
reactions for the regulation of activation of the 
classical and alternative pathway C3 convertase. 
The I-catalyzed C3b cleavage requires cofactor 
proteins, such as factor H, C4bp, or CR1 and pro- 
duces a nicked C3b, iC3b, which has the same 
molecular mass as C3b but consisted of the three 
disulfide-linked polypeptide chains, two LY’ chain 
fragments and intact ,6 chain [9,13]. The cleavage 
of cy’ chain of C3b is responsible for the inactiva- 
tion of C3b [9,13]. iC3b is a stable product of I- 
catalyzed C3b cleavage and is cleaved further into 
C3c and C3dg only when iC3b was incubated with 
factor I in the presence of CR1 [12]. In the case of 
C4b cleavage, nicked C4b was so rapidly cleaved 
into C4c and C4d that it was difficult to isolate 
C4b’ and to assess whether C4b’ is functionally 
active or inactive C4b derivative. The present 
paper demonstrates that C4b’ still retains the abili- 
ty to assemble C3 convertase with C2 as intact 
C4b. This seems to be compatible with evidence 
that C4b’ is not a stable intermediate as iC3b but 
is rapidly cleaved into C4c and C4d. 
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